Immunological Mechanisms of Rejection in Uterine Transplantation

Recruiting N/A Interventional Study
Transplant Rejection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Study type
Interventional
Purpose
Other
Participants needed
30 (estimated)
Sponsor
Hopital Foch · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The objective of this study is to understand the mechanisms of rejection in uterine transplantation and to search for non-invasive markers of rejection. The biological samples necessary for our research have been or will be collected during procedures (biopsies, smears, vaginal swab, blood tests) carried out as part of the scheduled follow-up of patients. These will be samples whose collection is …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient going to or having received a uterine transplant OR Patient going to or having donated a uterus for a recipient included in the study OR Premenopausal woman to undergo gynecological surgery under general anesthesia: for 4 of them it was a hysterectomy and they must be …
Contacts

Marie Carbonnel, MD

+331 46 25 48 53

m.carbonnel@hopital-foch.com

CONTACT

Elisabeth Hulier-Ammar

+331 46 25 11 75

drci-promotion@hopital-foch.com

CONTACT